By Professor Nada Hamad

Journal articles

Fifer S; Godsell J; Opat S; Hamad N; Lasica M; Forsyth C; Morand L; Smeaton E; Winton S; Puig A; McGeachie M, 2024, 'Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia', BMC Cancer, 24, http://dx.doi.org/10.1186/s12885-024-12589-9

Garderet L; Gras L; Koster L; Baaij L; Hamad N; Dsouza A; Estrada-Merly N; Hari P; Saber W; Cowan AJ; Iida M; Okamoto S; Takamatsu H; Mizuno S; Kawamura K; Kodera Y; Ko BS; Liam C; Ho KW; Goh AS; Tan SK; Elhaddad AM; Bazarbachi A; Chaudhry QUN; Alfar R; Bekadja MA; Benakli M; Ortiz CAF; Riva E; Galeano S; Bass F; Mian HS; McCurdy A; Wang FR; Meng L; Neumann D; Koh M; Snowden JA; Schönland S; McLornan DP; Hayden PJ; Sureda A; Greinix HT; Aljurf M; Atsuta Y; Niederwieser D, 2024, 'Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)', American Journal of Hematology, 99, pp. 2084 - 2095, http://dx.doi.org/10.1002/ajh.27451

Atsuta Y; Baldomero H; Neumann D; Sureda A; DeVos JD; Iida M; Karduss A; Purtill D; Elhaddad AM; Bazuaye NG; Bonfim C; de la Camara R; Chaudhri NA; Ciceri F; Correa C; Frutos C; Galeano S; Garderet L; Gonzalez-Ramella O; Greco R; Hamad N; Hazenberg MD; Horowitz MM; Kalwak K; Ko BS; Kodera Y; Koh MBC; Liu K; McLornan DP; Moon JH; Neven B; Okamoto S; Pasquini MC; Passweg JR; Paulson K; Rondelli D; Ruggeri A; Seber A; Snowden JA; Srivastava A; Szer J; Weisdorf D; Worel N; Greinix H; Saber W; Aljurf M; Niederwieser D, 2024, 'Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors', Haematologica, 109, pp. 3282 - 3294, http://dx.doi.org/10.3324/haematol.2024.285002

Fleming S; Scott AP; Coutsouvelis J; Fraser C; Bajel A; Nelson A; Conyers R; McEwan A; Yeung D; Campion V; Teague L; McGuire M; Morris E; Gabriel M; Wayte R; Douglas G; Chien N; Hamad N, 2024, 'ANZTCT practice statement: sinusoidal obstruction syndrome/veno-occlusive disease diagnosis and management', Internal Medicine Journal, 54, pp. 1548 - 1556, http://dx.doi.org/10.1111/imj.16453

Blennerhassett R; Hamad N; Grech L; Kwok A; Choi T; Forsyth C; Jagger J; Opat S; Harris S; Chan BA; Nguyen M; Bain N; Day D; Segelov E, 2024, 'Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies', Acta Haematologica, 147, pp. 543 - 554, http://dx.doi.org/10.1159/000536548

Iqbal M; Kumar A; Dreger P; Chavez J; Sauter CS; Sureda AM; Bachanova V; Maziarz RT; Dreyling M; Smith SM; Jacobson C; Glass B; Casulo C; Oluwole OO; Montoto S; Advani R; Cohen J; Salles G; Hamad N; Kuruvilla J; Kahl BS; Shadman M; Kanate AS; Budde LE; Kamdar M; Flowers C; Hamadani M; Kharfan-Dabaja MA, 2024, 'Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation', Transplantation and Cellular Therapy, 30, pp. 832 - 843, http://dx.doi.org/10.1016/j.jtct.2024.06.025

Shi CR; Ferreira AL; Kaur M; Xiang D; Caputo J; Choe HK; Hamad N; Cowen EW; Kaffenberger BH; Baumrin E, 2024, 'Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care', Transplantation and Cellular Therapy, 30, pp. S513 - S533, http://dx.doi.org/10.1016/j.jtct.2024.05.020

Hamad N, 2024, 'Precision medicine may mitigate racial biases', Blood, 144, pp. 927 - 929, http://dx.doi.org/10.1182/blood.2024025880

Jain T; Estrada-Merly N; Salas MQ; Kim S; DeVos J; Chen M; Fang X; Kumar R; Andrade-Campos M; Elmariah H; Agrawal V; Aljurf M; Bacher U; Badar T; Badawy SM; Ballen K; Beitinjaneh A; Bhatt VR; Bredeson C; De Filipp Z; Dholaria B; Farhadfar N; Farhan S; Gandhi AP; Ganguly S; Gergis U; Grunwald MR; Hamad N; Hamilton BK; Inamoto Y; Iqbal M; Jamy O; Juckett M; Kharfan-Dabaja MA; Krem MM; Lad DP; Liesveld J; Al Malki MM; Malone AK; Murthy HS; Ortí G; Patel SS; Pawarode A; Perales MA; Van Der Poel M; Ringden O; Rizzieri DA; Rovó A; Savani BN; Savoie ML; Seo S; Solh M; Ustun C; Verdonck LF; Wingard JR; Wirk B; Bejanyan N; Jones RJ; Nishihori T; Oran B; Nakamura R; Scott B; Saber W; Gupta V, 2024, 'Donor types and outcomes of transplantation in myelofibrosis: A CIBMTR study', Blood Advances, 8, pp. 4281 - 4293, http://dx.doi.org/10.1182/bloodadvances.2024013451

Hamad N, 2024, 'Aspiring to equity: race vs ethnicity in clinical research', Blood Advances, 8, pp. 3823 - 3824, http://dx.doi.org/10.1182/bloodadvances.2024013028

Baggio D; Chung E; Wellard C; Waters N; Cushion T; Chong G; Cochrane T; Cull G; Giri P; Hamad N; Johnston A; Lee D; Murali A; Morgan S; Mulligan S; Talaulikar D; Ratnasingam S; Wood E; Hawkes E; Opat S, 2024, 'Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era', Internal Medicine Journal, 54, pp. 1223 - 1227, http://dx.doi.org/10.1111/imj.16445

Manos K; Churilov L; Grigg A; Di Ciaccio P; Wong J; Chandra Sekaran U; Wight J; Goh Z; Jina H; Butler L; Yannakou CK; Hamad N; Gregory GP; Gangatharan S; Cochrane T; Hawkes EA; Lasica M, 2024, 'Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study', British Journal of Haematology, 205, pp. 146 - 157, http://dx.doi.org/10.1111/bjh.19407

Binkley MS; Flerlage JE; Savage KJ; Akhtar S; Steiner R; Zhang XY; Dickinson M; Prica A; Major A; Hendrickson PG; Hopkins D; Ng A; Casulo C; Baron J; Roberts KB; Al Kendi J; Balogh A; Ricardi U; Torka P; Specht L; De Silva R; Pickard K; Blazin LJ; Henry M; Smith CM; Halperin D; Brady J; Brennan B; Senchenko MA; Reeves M; Hoppe BS; Terezakis S; Talaulikar D; Picardi M; Kirova Y; Fergusson P; Hawkes EA; Lee D; Doo NW; Barraclough A; Cheah CY; Ku M; Hamad N; Mutsando H; Gilbertson M; Marconi T; Viiala N; Maurer MJ; Eichenauer DA; Hoppe RT; Borchmann P; Fuchs M; Hartmann S; Eich HT; Lo AC; Skinnider B; Rauf MS; Maghfoor I; Pinnix CC; Milgrom SA; Vega F; Alomari M; Collins GP; Advani RH; Metzger ML; Wirth A; Tsang R; Smith S; Kelsey CR; McKay P; Koenig J; Constine LS; Sakthivel KG; Plastaras JP; Gao S; Al Rahbi N; Levis M; Sridhar A; Shah N; Osborne W; Chang I; Miall F; Mikhaeel G; Penn A; Volchkov EV; Della Pepa R; Northend M; Opat S; Salvaris R; Tedjaseputra A; Palese M; Shankar A; Natkunam Y; Kelly KM, 2024, 'International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma', Journal of Clinical Oncology, 42, pp. 2271 - 2280, http://dx.doi.org/10.1200/JCO.23.01655

Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemary M; Elsawy M; Guilcher GMT; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R, 2024, 'International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update', Bone Marrow Transplantation, 59, pp. 717 - 741, http://dx.doi.org/10.1038/s41409-023-02190-2

Lasica M; Anderson MA; Boussioutas A; Gregory GP; Hamad N; Manos K; McKelvie P; Ng M; Campbell B; Palfreyman E; Salvaris R; Weinkove R; Wight J; Opat S; Tam C, 2024, 'Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance', Internal Medicine Journal, 54, pp. 1017 - 1030, http://dx.doi.org/10.1111/imj.16390

Hewitt J; Hamad N; Beecher C; Turner T; Chakraborty S, 2024, 'Poor reporting limited consideration of EDI in the Australian guidelines for the clinical care of people with COVID-19', Journal of Clinical Epidemiology, 170, http://dx.doi.org/10.1016/j.jclinepi.2024.111361

Baldomero H; Neumann D; Hamad N; Atsuta Y; Sureda A; Iida M; Karduss A; Elhaddad AM; Bazuaye NG; Bonfim C; Camara RDL; Chaudhri NA; Ciceri F; Correa C; Frutos C; Galeano S; Garderet L; Greco R; Jaimovich G; Kodera Y; Koh MB; Liu K; Ljungman P; McLornan DP; Nair G; Okamoto S; Pasquini MC; Passweg J; Paulson K; Ruggeri A; Seber A; Snowden JA; Srivastava A; Worel N; Saber W; Rondelli D; Aljurf M; Niederwieser D, 2024, 'The role of registries in hematological disorders', Best Practice and Research: Clinical Haematology, 37, http://dx.doi.org/10.1016/j.beha.2024.101556

Rotz SJ; Bhatt NS; Hamilton BK; Duncan C; Aljurf M; Atsuta Y; Beebe K; Buchbinder D; Burkhard P; Carpenter PA; Chaudhri N; Elemuary M; Elsawy M; Guilcher GM; Hamad N; Karduss A; Peric Z; Purtill D; Rizzo D; Rodrigues M; Ostriz MBR; Salooja N; Schoemans H; Seber A; Sharma A; Srivastava A; Stewart SK; Baker KS; Majhail NS; Phelan R, 2024, 'International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update', Transplantation and Cellular Therapy, 30, pp. 349 - 385, http://dx.doi.org/10.1016/j.jtct.2023.12.001

Fotheringham P; Safi N; Li Z; Anazodo A; Remond M; Hayen A; Currow D; Roder D; Hamad N; Nicholl M; Gordon A; Frawley J; Sullivan EA, 2024, 'Pregnancy-associated gynecological cancer in New South Wales, Australia 1994–2013: A population-based historical cohort study', Acta Obstetricia et Gynecologica Scandinavica, 103, pp. 729 - 739, http://dx.doi.org/10.1111/aogs.14530

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson AM; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2024, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies', Transplantation and Cellular Therapy, 30, pp. 334.e1 - 334.e7, http://dx.doi.org/10.1016/j.jtct.2023.11.018

Minson A; Hamad N; Cheah CY; Tam C; Blombery P; Westerman D; Ritchie D; Morgan H; Holzwart N; Lade S; Anderson MA; Khot A; Seymour JF; Robertson M; Caldwell I; Ryland G; Saghebi J; Sabahi Z; Xie J; Koldej R; Dickinson M, 2024, 'CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study', Blood, 143, pp. 673 - 684, http://dx.doi.org/10.1182/blood.2023021306

Campbell A; Teh B; Mulligan S; Ross DM; Weinkove R; Gilroy N; Gangatharan S; Prince HM; Szer J; Trotman J; Lane S; Dickinson M; Quach H; Enjeti AK; Ku M; Gregory G; Hapgood G; Ho PJ; Cochrane T; Cheah C; Greenwood M; Latimer M; Berkahn L; Wight J; Armytage T; Diamond P; Tam CS; Hamad N, 2024, 'Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignancies', Internal Medicine Journal, 54, pp. 328 - 336, http://dx.doi.org/10.1111/imj.16303

Peacock A; Dehle F; Mesa Zapata O; Gennari F; Williams M; Hamad N; Larsen S; Harrison S; Taylor C, 2024, 'Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease', Journal of Health Economics and Outcomes Research, pp. 23 - 31, http://dx.doi.org/10.36469/jheor.2024.92028

Minson A; Hamad N; Di Ciaccio P; Talaulikar D; Ku M; Ratnasingam S; Cheah C; Yannakou CK; Bishton M; Ng ZY; Agrawal S; McQuillan A; Johnston A; Choong E; Wong K; McQuillan J; Beekman A; Hawkes E; Dickinson M, 2024, 'Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom', British Journal of Haematology, 204, pp. 548 - 554, http://dx.doi.org/10.1111/bjh.19179

Di Ciaccio PR; Polizzotto MN; Cwynarski K; Gerrie AS; Burton C; Bower M; Kuruvilla J; Montoto S; McKay P; Fox CP; Milliken S; Jiamsakul A; Osborne W; Collins GP; Manos K; Linton KM; Iyengar S; Kassam S; Limei MP; Kliman D; Wong Doo N; Watson AM; Fedele P; Yannakou CK; Hunt S; Ku M; Sehn LH; Smith A; Renshaw H; Maxwell A; Liu Q; Dhairyawan R; Ferguson G; Pickard K; Painter D; Thakrar N; Song KW; Hamad N, 2024, 'The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma', Blood, 143, pp. 152 - 165, http://dx.doi.org/10.1182/blood.2023021348

Peacock A; Dehle FC; Mesa Zapata OA; Gennari F; Williams MRI; Hamad N; Larsen S; Harrison SJ; Taylor C, 2024, 'Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease', Journal of Health Economics and Outcomes Research, 11, pp. 23 - 31, http://dx.doi.org/10.36469/001c.92028

Hamad N, 2024, 'How I approach intersectionality in hematopoietic stem cell transplantation', Blood, http://dx.doi.org/10.1182/blood.2023020778

Kröger N; Bacigalupo A; Barbui T; Ditschkowski M; Gagelmann N; Griesshammer M; Gupta V; Hamad N; Harrison C; Hernandez-Boluda JC; Koschmieder S; Jain T; Mascarenhas J; Mesa R; Popat UR; Passamonti F; Polverelli N; Rambaldi A; Robin M; Salit RB; Schroeder T; Scott BL; Tamari R; Tefferi A; Vannucchi AM; McLornan DP; Barosi G, 2024, 'Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group', The Lancet Haematology, 11, pp. e62 - e74, http://dx.doi.org/10.1016/S2352-3026(23)00305-8

Bekadja MA; Niederwiser D; Kharfan-Dabaja MA; El Fakih R; Garderet L; Yakoub-Agha I; Greinix H; Weisdorf DJ; Galeano S; Ahmed SO; Chabanon C; Hashmi SK; Ruggeri A; Gergis U; Bazarbachi A; Hamad N; Albeihany A; Pasquini M; Hanbali A; Szer J; Kodera Y; Kumar A; Elhassan T; McLornan D; Worel N; Greco R; Mohty M; Atsuta Y; Koh M; Sureda A; Rondelli D; Aljurf M; Rasheed W, 2024, 'Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation', Bone Marrow Transplantation, http://dx.doi.org/10.1038/s41409-024-02431-y

Shaw B; Chung E; Wellard C; Yoo E; Bennett R; Birks C; Johnston A; Cheah CY; Hamad N; Simpson J; Barraclough A; Ku M; Viiala N; Ratnasingam S; Armytage T; Cochrane T; Chong G; Lee D; Manos K; Keane C; Wallwork S; Opat S; Hawkes EA, 2024, 'Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.', EJHaem, 5, pp. 325 - 332, http://dx.doi.org/10.1002/jha2.870

Tatarczuch M; Lewis KL; Gunjur A; Shaw B; Poon LM; Paul E; Ku M; Wong M; Ai S; Beekman A; Ciaccio PRD; Krigstein M; Wight J; Coombes C; Gilbertson M; Tey A; Shortt J; Nagarajan C; Talaulikar D; Hamad N; Ratnasingam S; Ho S-J; Cochrane T; Hawkes EA; Cheah CY; Opat S; Gregory GP, 2024, 'Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.', EJHaem, 5, pp. 709 - 720, http://dx.doi.org/10.1002/jha2.951

Chai KL; Wellard C; Thao L; Aoki N; Moore EM; Augustson BM; Bapat A; Blacklock H; Chng WJ; Cooke R; Forsyth CJ; Goh Y-T; Hamad N; Harrison SJ; Ho PJ; Hocking J; Kerridge I; Kim JS; Kim K; King T; McCaughan GJ; Mollee P; Morrissey CO; Murphy N; Quach H; Tan XN; Tso AC; Wong KS; Yoon S-S; Spencer A; Wood EM; McQuilten ZK, 2024, 'Variation in immunoglobulin use and impact on survival in myeloma.', EJHaem, 5, pp. 690 - 697, http://dx.doi.org/10.1002/jha2.938

Lewis KL; Jakobsen LH; Villa D; Smedby KE; Savage KJ; Eyre TA; Cwynarski K; Bishton MJ; Fox CP; Hawkes EA; Maurer MJ; El-Galaly TC; Cheah CY; International CNS Prophylaxis Study Group , 2023, 'High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.', J Clin Oncol, 41, pp. 5376 - 5387, http://dx.doi.org/10.1200/JCO.23.00365

Hamad N; Bilmon I; Chee L; Henden A; Johnston A; Purtill D; Bajel A; Tey SK; Yeung D; Cole T; Lewis C; Butler J, 2023, 'ANZTCT consensus position statement on ruxolitinib in steroid-refractory acute and chronic graft-versus-host disease', Internal Medicine Journal, 53, pp. 2319 - 2329, http://dx.doi.org/10.1111/imj.16255

Gurnari C; Robin M; Godley LA; Drozd-Sokołowska J; Włodarski MW; Raj K; Onida F; Worel N; Ciceri F; Carbacioglu S; Kenyon M; Aljurf M; Bonfim C; Makishima H; Niemeyer C; Fenaux P; Zebisch A; Hamad N; Chalandon Y; Hellström-Lindberg E; Voso MT; Mecucci C; Duarte FB; Sebert M; Sicre de Fontbrune F; Soulier J; Shimamura A; Lindsley RC; Maciejewski JP; Calado RT; Yakoub-Agha I; McLornan DP, 2023, 'Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT', The Lancet Haematology, 10, pp. e994 - e1005, http://dx.doi.org/10.1016/S2352-3026(23)00265-X

Safi N; Li Z; Anazodo A; Remond M; Hayen A; Currow D; Roder D; Hamad N; Nicholl M; Gordon A; Frawley J; Fotheringham P; Sullivan E, 2023, 'Pregnancy associated cancer, timing of birth and clinical decision making—a NSW data linkage study', BMC Pregnancy and Childbirth, 23, http://dx.doi.org/10.1186/s12884-023-05359-1

Tang C; Zhang L; Suleman A; Lewis KL; Quinn D; Poon M; Hann W; Pringle E; Cherepanoff S; Coyle L; Kassam S; McKay P; Cheah CY; Prica A; Smith J; Hamad N, 2023, 'An International Multicenter Study of Primary Vitreoretinal Lymphoma from the Australasian Lymphoma Alliance and Collaborators', Blood, 142, pp. 3132 - 3132, http://dx.doi.org/10.1182/blood-2023-178431

Lewis KL; Blombery P; Sungala NP; Ma CKK; Giri P; Vanguru V; Cochrane T; Czerwinski JK; Lee D; Hamad N; Francis R; Walia M; Carlson J; Butcher BE; Cheah CY, 2023, 'Australasian Leukaemia & Lymphoma Group NHL35-Pacific: An Open Label Phase II Study of Pembrolizumab and Chemo-Immunotherapy As First-Line Therapy for Primary Mediastinal B-Cell Lymphoma - Trial in Progress', Blood, 142, pp. 3103 - 3103, http://dx.doi.org/10.1182/blood-2023-185160

Mizuno S; Gras L; Baaij L; Koster L; D'Souza A; Hari PN; Estrada-Merly N; Saber W; Cowan AJ; Iida M; Okamoto S; Takamatsu H; Kawamura K; Kodera Y; Hamad N; Ko B-S; Liam C; HO KIMW; Goh AS; Tan SK; Elhaddad AM; Bazarbachi A; Chaudhry BQUN; Alfar R; Bekadja MA; Benakli M; Frutos Ortiz CA; Riva E; Galeano S; Bass F; Mian H; McCurdy A; Wang FR; Neumann D; Koh MBC; Snowden J; Schönland S; McLornan DP; Hayden PJ; Sureda Balari AM; Greinix HT; Aljurf M; Atsuta Y; Niederwieser DW; Garderet L, 2023, 'Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study', Blood, 142, pp. 785 - 785, http://dx.doi.org/10.1182/blood-2023-179153

Rajasekariah H; McCaughan G; Ma CKK; Gorrie N; Milliken S; Ma D; Fay K; Withers B; Hamad N; Birch S; Keogh A; Jabbour A; Hayward C; Macdonald P; Moore J, 2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319

Zeiser R; Russo D; Ram R; Hashmi SK; Chakraverty R; Middeke JM; Musso M; Giebel S; Uzay A; Langmuir P; Hamad N; Li X; Gowda M; Stefanelli T; Lee SJ; Teshima T; Locatelli F, 2023, 'Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study', Blood, 142, pp. 654 - 654, http://dx.doi.org/10.1182/blood-2023-172590

Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907

Pabst T; Papayannidis C; Demirkan F; Doronin V; Fogliatto LM; Guttke C; Gyan E; Hamad N; Herrera P; Hultberg A; Jacobs J; Johnson AJ; Langlois A; Ma X; Martinelli G; Arnan M; Müller R; Nottage K; Ofran Y; Özcan M; Samoilova O; Tolbert JA; Trudel GC; Xiu L; Vey N; Wei AH, 2023, 'Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study', The Lancet Haematology, 10, pp. e902 - e912, http://dx.doi.org/10.1016/S2352-3026(23)00207-7

Blennerhassett R; Othman J; Biscoe A; Kliman D; Mills G; Blyth E; Micklethwaite K; Kwan J; Bilmon I; Bhattacharyya A; Panicker S; Fay K; Milliken S; Ma D; Hamad N; Stevenson W; Arthur C; Moore J; Greenwood M; Gottlieb D; Kerridge I, 2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal, 53, pp. 1979 - 1986, http://dx.doi.org/10.1111/imj.16043

Luke JJ; Patel MR; Blumenschein GR; Hamilton E; Chmielowski B; Ulahannan SV; Connolly RM; Santa-Maria CA; Wang J; Bahadur SW; Weickhardt A; Asch AS; Mallesara G; Clingan P; Dlugosz-Danecka M; Tomaszewska-Kiecana M; Pylypenko H; Hamad N; Kindler HL; Sumrow BJ; Kaminker P; Chen FZ; Zhang X; Shah K; Smith DH; De Costa A; Li J; Li H; Sun J; Moore PA, 2023, 'The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial', Nature Medicine, 29, pp. 2814 - 2824, http://dx.doi.org/10.1038/s41591-023-02593-0

Farooq F; Brandt JS; Cardonick E; Polushkina E; Vose J; Ahmed S; Geethakumari PR; Olszewski AJ; Yasin H; Farooq U; Hamad N; Lin Y; Maggen C; Fruscio R; Gziri MM; Steffensen KD; Amant F; Evens AM, 2023, 'An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy', Blood Advances, 7, pp. 5480 - 5484, http://dx.doi.org/10.1182/bloodadvances.2023010090

Moore J; Hamad N; Gottlieb D; Bajel A; Ritchie D; Yeung D; Greenwood M; Purtill D; Tran S; Solterbeck A; Aarons D; Kwan J, 2023, 'Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study', Blood Advances, 7, pp. 5554 - 5565, http://dx.doi.org/10.1182/bloodadvances.2023009840

Barraclough A; England JT; Villa D; Wight J; Hapgood G; Conn J; Doo NW; Li EW; Gilbertson M; Shaw B; Bishton MJ; Saeed M; Ratnasingam S; Abeyakoon C; Chong G; Wai SH; Ku M; Lee HP; Fleming K; Tam C; Douglas G; Cheah CY; Ng ZY; Rolfe T; Mills AK; Hamad N; Cashman H; Gleeson M; Narayana M; Hawkes EA, 2023, 'Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance', Haematologica, 108, pp. 2444 - 2453, http://dx.doi.org/10.3324/haematol.2022.281375

Taher A; Abadir E; McCluskey P; Hamad N; Lo TH; Heydon P, 2023, 'PRESUMPTIVE RECURRENCE OF INTRAOCULAR LYMPHOMA DESPITE CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY', Retinal Cases and Brief Reports, 17, pp. 562 - 566, http://dx.doi.org/10.1097/ICB.0000000000001246

Novitzky-Basso I; Linn SM; White J; Elemary M; Xenocostas A; Deotare U; Kelly K; Hamad N; Tan S; Culos S; Law A; Kumar R; Mattsson J; Kim DDH, 2023, 'Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure', Bone Marrow Transplantation, 58, pp. 1024 - 1032, http://dx.doi.org/10.1038/s41409-023-02020-5

Back to profile page